Sfoglia per Autore
Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components
2009-01-01 Marchiò C; Iravani M; Natrajan R; Lambros MB; Geyer FC; Savage K; Parry S; Tamber N; Fenwick K; Mackay A; Schmitt FC; Bussolati G; Ellis I; Ashworth A; Sapino A; Reis-Filho JS
The role of molecular analysis in breast cancer.
2009-01-01 Geyer FC; Marchio C; Reis-Filho JS.
Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?
2009-01-01 Natrajan R; Lambros MB; Geyer FC; Marchio C; Tan DS; Vatcheva R; Shiu KK; Hungermann D; Rodriguez-Pinilla SM; Palacios J; Ashworth A; Buerger H; Reis-Filho JS.
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas.
2009-01-01 Tan DS; Lambros MB; Rayter S; Natrajan R; Vatcheva R; Gao Q; Marchiò C; Geyer FC; Savage K; Parry S; Fenwick K; Tamber N; Mackay A; Dexter T; Jameson C; McCluggage WG; Williams A; Graham A; Faratian D; El-Bahrawy M; Paige AJ; Gabra H; Gore ME; Zvelebil M; Lord CJ; Kaye SB; Ashworth A; Reis-Filho JS.
Tiling path genomic profiling of grade 3 invasive ductal breast cancers.
2009-01-01 Natrajan R; Lambros MB; Rodríguez-Pinilla SM; Moreno-Bueno G; Tan DS; Marchió C; Vatcheva R; Rayter S; Mahler-Araujo B; Fulford LG; Hungermann D; Mackay A; Grigoriadis A; Fenwick K; Tamber N; Hardisson D; Tutt A; Palacios J; Lord CJ; Buerger H; Ashworth A; Reis-Filho JS.
CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification.
2010-01-01 Klingbeil P; Natrajan R; Everitt G; Vatcheva R; Marchio C; Palacios J; Buerger H; Reis-Filho JS; Isacke CM.
Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.
2010-01-01 Righi L; Sapino A; Marchiò C; Papotti M; Bussolati G.
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer
2010-01-01 N. Turner; A. Pearson; R. Sharpe; M. Lambros; F. Geyer; M. A. Lopez Garcia; R. Natrajan; C. Marchiò; E. Iorns; A. Mackay; C. Gillett; A. Grigoriadis; A. Tutt; J.S. Reis Filho; A. Ashworth
Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas).
2010-01-01 C. Marchiò;B. Weigelt;J. S. Reis-Filho
Breast cancer precursors revisited: molecular features and progression pathways.
2010-01-01 M. A. Lopez-Garcia;F. C. Geyer;M. Lacroix-Triki;C. Marchió;J. S. Reis-Filho
Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study
2010-01-01 Castellano I; Marchiò C; Tomatis M; Ponti A; Casella D; Bianchi S; Vezzosi V; Arisio R; Pietribiasi F; Frigerio A; Mano MP; Ricardi U; Allia E; Accortanzo V; Durando A; Bussolati G; Tot T; Sapino A.
Chemotherapy with or without trastuzumab.
2010-01-01 Oakman C; Sapino A; Marchiò C; Pestrin M; Biganzoli L; Di Leo A.
The pathologic complete response open question in primary therapy
2011-01-01 Marchiò C; Sapino A
Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box
2011-01-01 C. Marchiò; M. Dowsett; J.S. Reis Filho
Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment.
2011-01-01 S. C. Drury;S. Detre;A. Leary;J. Salter;J. Reis-Filho;V. Barbashina;C. Marchio;E. Lopez-Knowles;Z. Ghazoui;K. Habben;S. Arbogast;S. Johnston;M. Dowsett
Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis.
2012-01-01 Geyer FC;Lacroix-Triki M;Colombo PE;Patani N;Gauthier A;Natrajan R;Lambros MB;Khalifeh I;Albarracin C;Orru S;Marchiò C;Sapino A;Mackay A;Weigelt B;Schmitt FC;Wesseling J;Sneige N;Reis-Filho JS
Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes
2012-01-01 S. D. Palma;R. H. W;C. Marchiò;A. Skálová;M. Ungari;A. Sandison;S. Whitaker;S. Parry; J. S. Reis-Filho
Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection.
2012-01-01 L. Hernandez;P. M. Wilkerson;M. B. Lambros;A. Campion-Flora;D. N. Rodrigues;A. Gauthier;C. Cabral;V. Pawar;A. Mackay;R. A'hern;C. Marchiò;J. Palacios;R. Natrajan;B. Weigelt;J. S. Reis-Filho
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer.
2012-01-01 Annaratone L;Marchiò C;Renzulli T;Castellano I;Cantarella D;Isella C;Macrì L;Mariscotti G;Balmativola D;Cantanna E;Deambrogio C;Pietribiasi F;Arisio R;Schmitt F;Medico E;Sapino A
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines.
2013-01-01 Recupero D;Daniele L;Marchiò C;Molinaro L;Castellano I;Cassoni P;Righi A;Montemurro F;Sismondi P;Biglia N;Viale G;Risio M;Sapino A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components | 2009 | Marchiò C; Iravani M; Natrajan R; Lambros MB; Geyer FC; Savage K; Parry S; Tamber N; Fenwick K; Mackay A; Schmitt FC; Bussolati G; Ellis I; Ashworth A; Sapino A; Reis-Filho JS | |
| The role of molecular analysis in breast cancer. | 2009 | Geyer FC; Marchio C; Reis-Filho JS. | |
| Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype? | 2009 | Natrajan R; Lambros MB; Geyer FC; Marchio C; Tan DS; Vatcheva R; Shiu KK; Hungermann D; Rodriguez-Pinilla SM; Palacios J; Ashworth A; Buerger H; Reis-Filho JS. | |
| PPM1D is a potential therapeutic target in ovarian clear cell carcinomas. | 2009 | Tan DS; Lambros MB; Rayter S; Natrajan R; Vatcheva R; Gao Q; Marchiò C; Geyer FC; Savage K; Parry S; Fenwick K; Tamber N; Mackay A; Dexter T; Jameson C; McCluggage WG; Williams A; Graham A; Faratian D; El-Bahrawy M; Paige AJ; Gabra H; Gore ME; Zvelebil M; Lord CJ; Kaye SB; Ashworth A; Reis-Filho JS. | |
| Tiling path genomic profiling of grade 3 invasive ductal breast cancers. | 2009 | Natrajan R; Lambros MB; Rodríguez-Pinilla SM; Moreno-Bueno G; Tan DS; Marchió C; Vatcheva R; Rayter S; Mahler-Araujo B; Fulford LG; Hungermann D; Mackay A; Grigoriadis A; Fenwick K; Tamber N; Hardisson D; Tutt A; Palacios J; Lord CJ; Buerger H; Ashworth A; Reis-Filho JS. | |
| CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification. | 2010 | Klingbeil P; Natrajan R; Everitt G; Vatcheva R; Marchio C; Palacios J; Buerger H; Reis-Filho JS; Isacke CM. | |
| Neuroendocrine differentiation in breast cancer: established facts and unresolved problems. | 2010 | Righi L; Sapino A; Marchiò C; Papotti M; Bussolati G. | |
| FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer | 2010 | N. Turner; A. Pearson; R. Sharpe; M. Lambros; F. Geyer; M. A. Lopez Garcia; R. Natrajan; C. Marchiò; E. Iorns; A. Mackay; C. Gillett; A. Grigoriadis; A. Tutt; J.S. Reis Filho; A. Ashworth | |
| Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas). | 2010 | C. Marchiò;B. Weigelt;J. S. Reis-Filho | |
| Breast cancer precursors revisited: molecular features and progression pathways. | 2010 | M. A. Lopez-Garcia;F. C. Geyer;M. Lacroix-Triki;C. Marchió;J. S. Reis-Filho | |
| Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study | 2010 | Castellano I; Marchiò C; Tomatis M; Ponti A; Casella D; Bianchi S; Vezzosi V; Arisio R; Pietribiasi F; Frigerio A; Mano MP; Ricardi U; Allia E; Accortanzo V; Durando A; Bussolati G; Tot T; Sapino A. | |
| Chemotherapy with or without trastuzumab. | 2010 | Oakman C; Sapino A; Marchiò C; Pestrin M; Biganzoli L; Di Leo A. | |
| The pathologic complete response open question in primary therapy | 2011 | Marchiò C; Sapino A | |
| Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box | 2011 | C. Marchiò; M. Dowsett; J.S. Reis Filho | |
| Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment. | 2011 | S. C. Drury;S. Detre;A. Leary;J. Salter;J. Reis-Filho;V. Barbashina;C. Marchio;E. Lopez-Knowles;Z. Ghazoui;K. Habben;S. Arbogast;S. Johnston;M. Dowsett | |
| Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis. | 2012 | Geyer FC;Lacroix-Triki M;Colombo PE;Patani N;Gauthier A;Natrajan R;Lambros MB;Khalifeh I;Albarracin C;Orru S;Marchiò C;Sapino A;Mackay A;Weigelt B;Schmitt FC;Wesseling J;Sneige N;Reis-Filho JS | |
| Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes | 2012 | S. D. Palma;R. H. W;C. Marchiò;A. Skálová;M. Ungari;A. Sandison;S. Whitaker;S. Parry; J. S. Reis-Filho | |
| Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection. | 2012 | L. Hernandez;P. M. Wilkerson;M. B. Lambros;A. Campion-Flora;D. N. Rodrigues;A. Gauthier;C. Cabral;V. Pawar;A. Mackay;R. A'hern;C. Marchiò;J. Palacios;R. Natrajan;B. Weigelt;J. S. Reis-Filho | |
| High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer. | 2012 | Annaratone L;Marchiò C;Renzulli T;Castellano I;Cantarella D;Isella C;Macrì L;Mariscotti G;Balmativola D;Cantanna E;Deambrogio C;Pietribiasi F;Arisio R;Schmitt F;Medico E;Sapino A | |
| Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines. | 2013 | Recupero D;Daniele L;Marchiò C;Molinaro L;Castellano I;Cassoni P;Righi A;Montemurro F;Sismondi P;Biglia N;Viale G;Risio M;Sapino A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile